Literature DB >> 10199327

Paraneoplastic syndromes.

J O Dalmau1, J B Posner.   

Abstract

The fact that a small cancer hidden in the chest, abdomen, or pelvis could destroy or damage portions of the nervous system, such as cerebellar Purkinje cells or cholinergic synapses, has intrigued neurologists since paraneoplastic syndromes were first described. In 1965, when little was known about their pathogenesis, a full issue of the journal Brain and an international symposium were devoted to paraneoplastic disorders. In this decade, the discovery of several paraneoplastic antibodies that react with both the nervous system and the causal cancer has rekindled interest in these syndromes (Table). Several other factors make these rare syndromes of clinical and scientific interest. A recent review by Dalmau and Posner contains a more comprehensive bibliography of paraneoplastic syndromes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10199327     DOI: 10.1001/archneur.56.4.405

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  13 in total

1.  Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer.

Authors:  A O Güre; E Stockert; M J Scanlan; R S Keresztes; D Jäger; N K Altorki; L J Old; Y T Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

2.  Pancreatic cancer in a patient with myasthenia gravis.

Authors:  Rosalia Patti; Eraldo Natalè; Alberto Maringhini
Journal:  Dig Dis Sci       Date:  2004-06       Impact factor: 3.199

3.  Ataxia associated with Hashimoto's disease: progressive non-familial adult onset cerebellar degeneration with autoimmune thyroiditis.

Authors:  M Selim; D A Drachman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-07       Impact factor: 10.154

4.  Association between the neuron-specific RNA-binding protein ELAVL4 and Parkinson disease.

Authors:  Maher A Noureddine; Xue-Jun Qin; Sofia A Oliveira; Tara J Skelly; Joelle van der Walt; Michael A Hauser; Margaret A Pericak-Vance; Jeffery M Vance; Yi-Ju Li
Journal:  Hum Genet       Date:  2005-04-13       Impact factor: 4.132

Review 5.  Diagnosis and current treatment of neurological paraneoplastic syndromes.

Authors:  María José Molina-Garrido; Carmen Guillén-Ponce; Salvador Martínez; María Guirado-Risueño
Journal:  Clin Transl Oncol       Date:  2006-11       Impact factor: 3.405

6.  Paraneoplastic syndromes in patients with primary malignancies of the head and neck. Four cases and a review of the literature.

Authors:  L W J Baijens; J J Manni
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-06-29       Impact factor: 2.503

7.  Cerebellar hypermetabolism in paraneoplastic cerebellar degeneration.

Authors:  K-D Choi; J S Kim; S-H Park; Y K Kim; S E Kim; P S Smitt
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

Review 8.  Paraneoplastic syndromes in patients with primary head and neck cancer.

Authors:  Alfio Ferlito; Mohamed N Elsheikh; Johannes J Manni; Alessandra Rinaldo
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-01-06       Impact factor: 3.236

9.  Paraneoplastic neurologic syndrome: A practical approach.

Authors:  Sudheeran Kannoth
Journal:  Ann Indian Acad Neurol       Date:  2012-01       Impact factor: 1.383

10.  Hodgkin's lymphoma presenting as a complex paraneoplastic neurological syndrome: a case report.

Authors:  Nischala Ammannagari; Shailaja Chikoti; Eric Bravin
Journal:  J Med Case Rep       Date:  2013-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.